114 related articles for article (PubMed ID: 7829527)
21. Effect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter.
Kim SH; Lee SH; Kwak NH; Kang CD; Chung BS
Cancer Lett; 1996 Jan; 98(2):199-205. PubMed ID: 8556709
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
Ludes-Meyers JH; Subler MA; Shivakumar CV; Munoz RM; Jiang P; Bigger JE; Brown DR; Deb SP; Deb S
Mol Cell Biol; 1996 Nov; 16(11):6009-19. PubMed ID: 8887630
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris GF; Bischoff JR; Mathews MB
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
25. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.
Sampath J; Sun D; Kidd VJ; Grenet J; Gandhi A; Shapiro LH; Wang Q; Zambetti GP; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39359-67. PubMed ID: 11483599
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
[TBL] [Abstract][Full Text] [Related]
27. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
Unger T; Nau MM; Segal S; Minna JD
EMBO J; 1992 Apr; 11(4):1383-90. PubMed ID: 1314165
[TBL] [Abstract][Full Text] [Related]
28. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
29. Modulation of interleukin-6-induced plasma protein secretion in hepatoma cells by p53 species.
Wang L; Rayanade RJ; Garcia D; Patel K; Pan H; Sehgal PB
J Biol Chem; 1995 Sep; 270(39):23159-65. PubMed ID: 7559462
[TBL] [Abstract][Full Text] [Related]
30. Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.
Stein U; Walther W; Shoemaker RH
J Cancer Res Clin Oncol; 1996; 122(5):275-82. PubMed ID: 8609150
[TBL] [Abstract][Full Text] [Related]
31. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
[TBL] [Abstract][Full Text] [Related]
32. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
Saifudeen Z; Du H; Dipp S; El-Dahr SS
J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
[TBL] [Abstract][Full Text] [Related]
33. Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita T; Harigai M; Hanada M; Reed JC
Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
[TBL] [Abstract][Full Text] [Related]
34. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
Kelavkar UP; Badr KF
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
[TBL] [Abstract][Full Text] [Related]
35. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
Pastorcic M; Das HK
J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation.
Zhan M; Yu D; Liu J; Glazer RI; Hannay J; Pollock RE
J Biol Chem; 2005 Feb; 280(6):4825-33. PubMed ID: 15563462
[TBL] [Abstract][Full Text] [Related]
37. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene.
Zhu Q; Center MS
DNA Cell Biol; 1996 Feb; 15(2):105-11. PubMed ID: 8634138
[TBL] [Abstract][Full Text] [Related]
38. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
39. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
Duan L; Ozaki I; Oakes JW; Taylor JP; Khalili K; Pomerantz RJ
J Virol; 1994 Jul; 68(7):4302-13. PubMed ID: 8207805
[TBL] [Abstract][Full Text] [Related]
40. Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells.
Mathieu MC; Lapierre I; Brault K; Raymond M
J Biol Chem; 2001 Feb; 276(7):4819-27. PubMed ID: 11096091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
